1. Home
  2. ADMA vs AVNT Comparison

ADMA vs AVNT Comparison

Compare ADMA & AVNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • AVNT
  • Stock Information
  • Founded
  • ADMA 2004
  • AVNT 1927
  • Country
  • ADMA United States
  • AVNT United States
  • Employees
  • ADMA N/A
  • AVNT N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • AVNT Major Chemicals
  • Sector
  • ADMA Health Care
  • AVNT Industrials
  • Exchange
  • ADMA Nasdaq
  • AVNT Nasdaq
  • Market Cap
  • ADMA 4.1B
  • AVNT 3.4B
  • IPO Year
  • ADMA N/A
  • AVNT 1993
  • Fundamental
  • Price
  • ADMA $21.31
  • AVNT $31.20
  • Analyst Decision
  • ADMA Strong Buy
  • AVNT Strong Buy
  • Analyst Count
  • ADMA 4
  • AVNT 5
  • Target Price
  • ADMA $22.50
  • AVNT $51.20
  • AVG Volume (30 Days)
  • ADMA 3.7M
  • AVNT 902.5K
  • Earning Date
  • ADMA 05-08-2025
  • AVNT 05-06-2025
  • Dividend Yield
  • ADMA N/A
  • AVNT 3.46%
  • EPS Growth
  • ADMA N/A
  • AVNT 121.98
  • EPS
  • ADMA 0.81
  • AVNT 1.84
  • Revenue
  • ADMA $426,454,000.00
  • AVNT $3,240,400,000.00
  • Revenue This Year
  • ADMA $18.45
  • AVNT $2.89
  • Revenue Next Year
  • ADMA $26.96
  • AVNT $4.23
  • P/E Ratio
  • ADMA $26.31
  • AVNT $16.96
  • Revenue Growth
  • ADMA 65.16
  • AVNT 3.11
  • 52 Week Low
  • ADMA $6.01
  • AVNT $27.86
  • 52 Week High
  • ADMA $23.64
  • AVNT $54.68
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 60.16
  • AVNT 36.68
  • Support Level
  • ADMA $17.30
  • AVNT $30.31
  • Resistance Level
  • ADMA $22.25
  • AVNT $32.06
  • Average True Range (ATR)
  • ADMA 1.50
  • AVNT 2.12
  • MACD
  • ADMA 0.16
  • AVNT -0.05
  • Stochastic Oscillator
  • ADMA 83.62
  • AVNT 33.04

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About AVNT Avient Corporation

Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.

Share on Social Networks: